Johnson & Johnson: Asthma trials

The registry lists 18 Asthma studies with Johnson & Johnson as lead sponsor. 1 are open to participants now and 1 have results posted.

Early Phase 1 2Phase 1 7Phase 2 8No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe AsthmaNot yet recruitingNCT07746687Phase 2
• A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent AsthmaCompletedNCT00207740Phase 2Results posted
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153TerminatedNCT02517359Phase 1
• A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic DermatitisCompletedNCT02345928Phase 1
• A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsCompletedNCT02343783Early Phase 1
• Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent AsthmaTerminatedNCT02243189Phase 1
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 DaysCompletedNCT02140320Phase 1
• A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent AsthmaCompletedNCT01823016Phase 2
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729CompletedNCT01813084Phase 1
• A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16CompletedNCT01704040Phase 1
• Sample Collection in Smoking AsthmaCompletedNCT01676467
• Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled AsthmaWithdrawnNCT01493882Phase 2
• A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary DiseaseCompletedNCT01274507Early Phase 1
• A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge ModelCompletedNCT01241422Phase 2
• A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With AsthmaCompletedNCT01195207Phase 1
• A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent AsthmaCompletedNCT00946569Phase 2
• A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent AsthmaWithdrawnNCT00675649Phase 2
• Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.TerminatedNCT00530166Phase 2